US$ 22.45
upcoming glp-1 drugs What to Make of the Coverage and Cost Landscape GLP-1 Agonists Weight Loss Drugs
Description
Epidemiology of type 2 diabetesGlobal burden of disease and forecasted trends

Compared to GLP-1 RAs, SGLT2is (WMD: 0.43

It has the advantages of oral use, weight reduction, and potential positive cardiovascular effects in clinical practice

The price is good

The active ingredient is the same but in some cases the dosage may be different

The two forms work similarly and have comparable results, but differ in dosing, absorption, and regimens
